DE102009034132A1 - Plasmaadaptierte und balancierte Gelatinelösung - Google Patents

Plasmaadaptierte und balancierte Gelatinelösung Download PDF

Info

Publication number
DE102009034132A1
DE102009034132A1 DE102009034132A DE102009034132A DE102009034132A1 DE 102009034132 A1 DE102009034132 A1 DE 102009034132A1 DE 102009034132 A DE102009034132 A DE 102009034132A DE 102009034132 A DE102009034132 A DE 102009034132A DE 102009034132 A1 DE102009034132 A1 DE 102009034132A1
Authority
DE
Germany
Prior art keywords
gelatin
pharmaceutical preparation
preparation according
mmol
physiologically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE102009034132A
Other languages
German (de)
English (en)
Inventor
Michael Boll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
B Braun Melsungen AG
Original Assignee
B Braun Melsungen AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B Braun Melsungen AG filed Critical B Braun Melsungen AG
Priority to DE102009034132A priority Critical patent/DE102009034132A1/de
Priority to PCT/EP2010/060210 priority patent/WO2011009797A2/de
Priority to BR112012001229A priority patent/BR112012001229A2/pt
Priority to KR1020127000796A priority patent/KR20120046160A/ko
Priority to MX2012000957A priority patent/MX2012000957A/es
Priority to EP10734480A priority patent/EP2456446A2/de
Priority to CN2010800330764A priority patent/CN102470147A/zh
Priority to DE202010018349.9U priority patent/DE202010018349U1/de
Priority to RU2012105925/15A priority patent/RU2012105925A/ru
Publication of DE102009034132A1 publication Critical patent/DE102009034132A1/de
Priority to IN419DEN2012 priority patent/IN2012DN00419A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE102009034132A 2009-07-20 2009-07-20 Plasmaadaptierte und balancierte Gelatinelösung Withdrawn DE102009034132A1 (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DE102009034132A DE102009034132A1 (de) 2009-07-20 2009-07-20 Plasmaadaptierte und balancierte Gelatinelösung
EP10734480A EP2456446A2 (de) 2009-07-20 2010-07-15 Plasmaadaptierte und balancierte gelatinelösung
BR112012001229A BR112012001229A2 (pt) 2009-07-20 2010-07-15 formulação farmacêutica aquosa, uso da formulação farmacêutica aquosa
KR1020127000796A KR20120046160A (ko) 2009-07-20 2010-07-15 혈장-적합 균형 젤라틴 용액
MX2012000957A MX2012000957A (es) 2009-07-20 2010-07-15 Solucion de gelatina adaptada y equilibrada al plasma.
PCT/EP2010/060210 WO2011009797A2 (de) 2009-07-20 2010-07-15 Plasmaadaptierte und balancierte gelatinelösung
CN2010800330764A CN102470147A (zh) 2009-07-20 2010-07-15 适用于血浆的平衡明胶溶液
DE202010018349.9U DE202010018349U1 (de) 2009-07-20 2010-07-15 Plasmaadaptierte und balancierte Gelatinelösung
RU2012105925/15A RU2012105925A (ru) 2009-07-20 2010-07-15 Адаптированный к плазме сбалансированный раствор желатина
IN419DEN2012 IN2012DN00419A (pt) 2009-07-20 2012-01-16

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102009034132A DE102009034132A1 (de) 2009-07-20 2009-07-20 Plasmaadaptierte und balancierte Gelatinelösung

Publications (1)

Publication Number Publication Date
DE102009034132A1 true DE102009034132A1 (de) 2011-01-27

Family

ID=43334706

Family Applications (2)

Application Number Title Priority Date Filing Date
DE102009034132A Withdrawn DE102009034132A1 (de) 2009-07-20 2009-07-20 Plasmaadaptierte und balancierte Gelatinelösung
DE202010018349.9U Expired - Lifetime DE202010018349U1 (de) 2009-07-20 2010-07-15 Plasmaadaptierte und balancierte Gelatinelösung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE202010018349.9U Expired - Lifetime DE202010018349U1 (de) 2009-07-20 2010-07-15 Plasmaadaptierte und balancierte Gelatinelösung

Country Status (9)

Country Link
EP (1) EP2456446A2 (pt)
KR (1) KR20120046160A (pt)
CN (1) CN102470147A (pt)
BR (1) BR112012001229A2 (pt)
DE (2) DE102009034132A1 (pt)
IN (1) IN2012DN00419A (pt)
MX (1) MX2012000957A (pt)
RU (1) RU2012105925A (pt)
WO (1) WO2011009797A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2651717B1 (es) * 2016-07-26 2018-11-16 Lara OLLER DUQUE Solución acuosa cristaloide isotónica

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60207053T2 (de) 2001-03-06 2006-04-20 Fuji Photo Film B.V. Rekombinante gelatineartige proteine zur verwendung als plasmaexpander

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA702706B (en) * 1969-04-28 1971-12-29 Knox Gelatine Inc Blood plasma substitute
EP0223906A3 (en) * 1982-10-29 1989-02-01 Synthetic Blood Corporation Gelatin based synthetic whole blood and a process for preparing the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60207053T2 (de) 2001-03-06 2006-04-20 Fuji Photo Film B.V. Rekombinante gelatineartige proteine zur verwendung als plasmaexpander

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Bonhard, K., Arzneim.-Forsch. 21, 1667 (1971)
Campbell, D. H. et al., Texas Rep. Biol. Med. 9, 235 (1951)
Nitschmann und Stoll, Pharm.-Ztg. 42, 1594 (1968)
Schmidt-Thome, J., A. Mager und H. H. Schone, Arzneim.-Forsch. 12, 378 (1962)
Tourtelotte, D. und H. E. Williams, in: Stainsby, G., Gelatin and Glue Research, 1958

Also Published As

Publication number Publication date
RU2012105925A (ru) 2013-08-27
DE202010018349U1 (de) 2015-10-28
WO2011009797A2 (de) 2011-01-27
MX2012000957A (es) 2012-03-06
KR20120046160A (ko) 2012-05-09
WO2011009797A3 (de) 2011-08-25
BR112012001229A2 (pt) 2016-03-01
CN102470147A (zh) 2012-05-23
EP2456446A2 (de) 2012-05-30
IN2012DN00419A (pt) 2015-05-15

Similar Documents

Publication Publication Date Title
EP1732953B1 (de) Hydroxyethylstärke
DE60131286T2 (de) Therapeutische verwendung eines rekombinanten erythropoietins omega mit hoher aktivität und verminderten nebenwirkungen
DE69929550T2 (de) Albumin enthaltende Lösung für die Peritonealdialyse
DE602004002585T2 (de) Laktathaltige pharmazeutische Zusammensetzung und deren Verwendungen
DE60207053T2 (de) Rekombinante gelatineartige proteine zur verwendung als plasmaexpander
DE69332959T2 (de) Lösungen für die Peritonealdialyse und deren Verwendung zum Verringern von Schädigungen an mesothelialen Zellen
DE2029455B2 (de) Verfahren zur Herstellung eines neuen Prothrombinkomplexes
DE69727811T2 (de) Verwendung einer glukosehaltigen lösung in der peritonealdialyse mit verminderter bildung von zersetzungsprodukten
Myers Fluid resuscitation
EP2506858B1 (de) Stärkederivatmischungen
Inciarte et al. Cardiovascular effects of vanadate in the dog
Mathews The therapeutic use of 25% human serum albumin in critically ill dogs and cats
DE102009034132A1 (de) Plasmaadaptierte und balancierte Gelatinelösung
Lundy et al. Dextran in supportive therapy, with comments on periston and gelatin
Hoffman et al. Management of lower nephron nephrosis: report of six cases
Smith et al. The fluid of choice for resuscitation of severe shock
Baron et al. Volume replacement
EP2110136A2 (de) Pharmazeutische Zusammensetzung zur Behandlung von hämorrhagischem Schock und seinen Folgeerscheinungen
Heneghan Contrast-induced acute renal failure
DE102009034131A1 (de) Infusionslösungen zur Prophylaxe und Therapie des Reperfusionssyndroms
Lundsgaard‐Hansen Treatment of Shock with Dextrans and Gelatins: Effects and Side Effects 1
EP1682167B1 (de) Verwendung hyperpolymerer hämoglobine zur behandlung eines lungenödems
Rieger Blood volume and plasma protein
EP0967986B1 (de) VERWENDUNG VON HUMANEM alpha 1-SAUREN GLYCOPROTEIN ZUR HERSTELLUNG EINER PHARMAZEUTISCHEN PRÄPARATION
Gosling Albumin: friend or foe?

Legal Events

Date Code Title Description
R120 Application withdrawn or ip right abandoned